The real-life management of glucose homeostasis abnormalities in pediatric onco-hematological diseases: data from a national survey

References

• Carly Y, Kerry M, Nassrein H, Terra A. Current cancer therapies and their influence on glucose control. World J Diabetes. 2021;12(7):1010–1025. doi:10.4239/wjd.v12.i7.1010.
   PubMed Web of Science ®Google Scholar
• Friedman DN, Hilden P, Moskowitz CS, et al. Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: a pilot study. Pediatr Blood Cancer. 2018;65(11):e27304. doi:10.1002/pbc.27304.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Soliman AT, Elsedfy H, et al. The ICET-A recommendations for the diagnosis and management of disturbances of glucose homeostasis in thalassemia major patients. Mediterr J Hematol Infect Dis. 2016;8(1):e2016058. doi:10.4084/MJHID.2016.058.
   PubMedGoogle Scholar
• Handelsman Y, Leroith D, Bloomgarden ZT, et al. Diabetes and cancer–an AACE/ACE consensus statement. Endocr Pract. 2013;19(4):675–693. Erratum in: Endocr Pract. 2013;19(5):899. doi:10.4158/EP13248.CS.
   PubMed Web of Science ®Google Scholar
• Ranc K, Jørgensen ME, Friis S, Carstensen B. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia. 2014;57(5):927–934. doi:10.1007/s00125-014-3186-z.
   PubMed Web of Science ®Google Scholar
• Pepe A, Meloni A, Rossi G, et al. Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study. Br J Haematol. 2013;163(4):520–527. doi:10.1111/bjh.12557.
   PubMed Web of Science ®Google Scholar
• Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation guidelines for the management of transfusion-dependent thalassemia. Hemasphere. 2022;6(8):e732. doi:10.1097/HS9.0000000000000732.
   PubMed Web of Science ®Google Scholar
• Childrens Oncology Group. Long term follow-up guidelines. Version 5.0; 2018. http://www.survivorshipguidelines.org/pdf/2018/cog_ltfu_guidelines_v5.pdf.
   Google Scholar
• JBDS-IP. Joint British Diabetes Societies for inpatient care, UK Chemotherapy Board. The management of Glycaemic control in patients with cancer; 2021. https://abcd.care/sites/abcd.care/files/site_uploads/JBDS_Guidelines_Archive/JBDS_17_Oncology_Guideline_Final_21052021_Archive.pdf.
   Google Scholar
• Clemente G, Giorgini M, Mancini M, Gallo M, AMD-Associazione Medici Diabetologi ‘Diabetes and Cancer’ Working Group. Diabetologists and oncologists attitudes towards treating diabetes in the oncologic patient: insights from an exploratory survey. Diabetes Res Clin Pract. 2018;143:420–427. doi:10.1016/j.diabres.2018.02.044.
   PubMed Web of Science ®Google Scholar
• Ball HL. Conducting online surveys. J Hum Lact. 2019;35(3):413–417. doi:10.1177/0890334419848734.
   PubMed Web of Science ®Google Scholar
• Grimes A, Mohamed A, Sopfe J, Hill R, Lynch J. Hyperglycemia during childhood cancer therapy: incidence, implications, and impact on outcomes. J Natl Cancer Inst Monogr. 2019;2019(54):132–138. doi:10.1093/jncimonographs/lgz022.
   PubMedGoogle Scholar
• He LN, Chen W, Yang Y, et al. Elevated prevalence of abnormal glucose metabolism and other endocrine disorders in patients with β-thalassemia major: a meta-analysis. Biomed Res Int. 2019;2019:6573497. doi:10.1155/2019/6573497.
   PubMed Web of Science ®Google Scholar
• McCormick MC, Sharp E, Kalpatthi R, et al. Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs. Pediatr Blood Cancer. 2020;67(9):e28475. doi:10.1002/pbc.28475.
   PubMed Web of Science ®Google Scholar
• Lu VM, Goyal A, Vaughan LS, McDonald KL. The impact of hyperglycemia on survival in glioblastoma: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2018;170:165–169. doi:10.1016/j.clineuro.2018.05.020.
   PubMed Web of Science ®Google Scholar
• Decker M, Sacks P, Abbatematteo J, De Leo E, Brennan M, Rahman M. The effects of hyperglycemia on outcomes in surgical high-grade glioma patients. Clin Neurol Neurosurg. 2019;179:9–13. doi:10.1016/j.clineuro.2019.02.011.
   PubMed Web of Science ®Google Scholar
• Zhang BH, Wang J, Xue HM, Chen C. Impact of chemotherapy-related hyperglycemia on prognosis of child acute lymphocytic leukemia. Asian Pac J Cancer Prev. 2014;15(20):8855–8859. doi:10.7314/apjcp.2014.15.20.8855.
   PubMedGoogle Scholar
• Welsch S, Sawadogo K, Brichard B, et al. Characterization and risk factors of hyperglycaemia during treatment of childhood hematologic malignancies. Diabet Med. 2022;39(2):e14720. doi:10.1111/dme.14720.
   PubMed Web of Science ®Google Scholar
• Joharatnam-Hogan N, Chambers P, Dhatariya K, Board R, Joint British Diabetes Society for Inpatient Care (JBDS), UK Chemotherapy Board (UKCB). A guideline for the outpatient management of glycaemic control in people with cancer. Diabet Med. 2022;39(1):e14636. doi:10.1111/dme.14636.
   PubMed Web of Science ®Google Scholar
• Fardet L, Fève B. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs. 2014;74(15):1731–1745. doi:10.1007/s40265-014-0282-9.
   PubMed Web of Science ®Google Scholar
• Gallo M, Gentile L, Arvat E, Bertetto O, Clemente G. Diabetology and oncology meet in a network model: union is strength. Acta Diabetol. 2016;53(4):515–524. doi:10.1007/s00592-016-0839-z.
   PubMed Web of Science ®Google Scholar
• Friedman DN, Tonorezos ES, Cohen P. Diabetes and metabolic syndrome in survivors of childhood cancer. Horm Res Paediatr. 2019;91(2):118–127. doi:10.1159/000495698.
   PubMed Web of Science ®Google Scholar
• Al-Futaisi A, Wali Y, El-Beshlawi I, Al-Riyami S, Almahrezi A. Case study: using a continuous glucose monitoring system in a patient with diabetes and beta-thalassemia hemoglobinopathy. Pediatr Hematol Oncol. 2009;26(7):515–519. doi:10.1080/08880010902975892.
   PubMed Web of Science ®Google Scholar
• Choudhary A, Giardina P, Antal Z, Vogiatzi M. Unreliable oral glucose tolerance test and haemoglobin A1C in beta thalassaemia major–a case for continuous glucose monitoring? Br J Haematol. 2013;162(1):132–135. doi:10.1111/bjh.12322.
   PubMed Web of Science ®Google Scholar
• Soliman AT, Yasin M, El-Awwa A, De Sanctis V. Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: pilot study. Indian J Endocrinol Metab. 2013;17(3):490–495. doi:10.4103/2230-8210.111647.
   PubMedGoogle Scholar
• El-Samahy MH, Tantawy AA, Adly AA, Abdelmaksoud AA, Ismail EA, Salah NY. Evaluation of continuous glucose monitoring system for detection of alterations in glucose homeostasis in pediatric patients with β-thalassemia major. Pediatr Diabetes. 2019;20(1):65–72. doi:10.1111/pedi.12793.
   PubMed Web of Science ®Google Scholar
• Godwin JL, Jaggi S, Sirisena I, et al. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer. J Immunother Cancer. 2017;5(1):40. doi:10.1186/s40425-017-0245-2.
   PubMedGoogle Scholar
• Hiestand A, Flory J, Chitkara R. Hospitalization as an opportunity to optimize glycemic control in oncology patients. Curr Diab Rep. 2019;19(12):149. doi:10.1007/s11892-019-1283-6.
   PubMed Web of Science ®Google Scholar
• Sopfe J, Vigers T, Pyle L, Giller RH, Forlenza GP. Safety and accuracy of factory-calibrated continuous glucose monitoring in pediatric patients undergoing hematopoietic stem cell transplantation. Diabetes Technol Ther. 2020;22(10):727–733. doi:10.1089/dia.2019.0521.
   PubMed Web of Science ®Google Scholar
• Fattorusso V, Nugnes R, Casertano A, Valerio G, Mozzillo E, Franzese A. Non-diabetic hyperglycemia in the pediatric age: why, how, and when to treat? Curr Diab Rep. 2018;18(12):140. doi:10.1007/s11892-018-1115-0.
   PubMed Web of Science ®Google Scholar
• Otto AM. Warburg effect(s)–a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab. 2016;4(1):5. doi:10.1186/s40170-016-0145-9.
   PubMedGoogle Scholar
• August DA, Huhmann MB, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parenter Enteral Nutr. 2009;33(5):472–500. doi:10.1177/0148607109341804.
   PubMed Web of Science ®Google Scholar
• Baillargeon J, Langevin A, Mullins J, et al. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2005;45(7):960–963. doi:10.1002/pbc.20320.
   PubMed Web of Science ®Google Scholar
• Aberer F, Hochfellner DA, Sourij H, Mader JK. A practical guide for the management of steroid induced hyperglycaemia in the hospital. J Clin Med. 2021;10(10):2154. doi:10.3390/jcm10102154.
   PubMed Web of Science ®Google Scholar
• Gregoriou K, Craigie I, Gibson B, Mason A, Shaikh MG. Risk factors and management of corticosteroid-induced hyperglycaemia in paediatric acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2020;67(2):e28085. doi:10.1002/pbc.28085.
   PubMed Web of Science ®Google Scholar